Immunome Inc.

NASDAQ: IMNM · Real-Time Price · USD
10.26
0.32 (3.22%)
At close: Aug 15, 2025, 3:59 PM
10.40
1.41%
After-hours: Aug 15, 2025, 06:45 PM EDT

Immunome Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-212.39M -205.11M -292.96M -305.35M -262.59M -232.03M -106.81M -21.96M -26.15M -29.51M -36.9M -36.96M -36.15M -32.47M -24.71M -20.93M -21.59M -19.06M
Depreciation & Amortization
2.61M 2.56M 2.1M 1.76M 1.36M 843K 728K 731K 679K 643K 631K 489K 661K 715K 755K 893K 784K 768K
Stock-Based Compensation
21.41M 19.29M 15.75M 13.16M 9.35M 7.16M 6.22M 4.7M 4.95M 5.25M 5.33M 5.2M 5.01M 4.43M 3.45M 2.55M 1.51M 800K
Other Working Capital
-19.66M -9.96M 5.35M 2.09M -6.9M -11.69M 12.61M 20.08M 26.34M 26.25M 2.92M 2.7M 1.62M 5.96M 998K -1.06M -1.72M -3.61M
Other Non-Cash Items
40.52M 46.8M 159.03M 210.56M 196.07M 190.87M 80.29M 4.17M 3.85M 3.26M 2.42M 187K 170K -7K 4K -9K 5.54M 6.11M
Deferred Income Tax
n/a n/a n/a 1.59M 1.59M 833K n/a -3.83M -3.83M -3.08M -2.24M n/a n/a -500K -500K -511K -511K -11K
Change in Working Capital
-30.84M -16.22M 5.29M -7.92M -6.42M -10.59M 12M 19.41M 24.75M 25.47M 2.24M 2.45M 5.1M 6.76M 2.78M 528K -1.6M -1.65M
Operating Cash Flow
-178.68M -152.68M -110.79M -86.19M -60.64M -42.91M -7.57M 3.21M 4.25M 1.86M -28.69M -28.81M -25.39M -21.07M -18.23M -17.48M -15.87M -13.61M
Capital Expenditures
-7.48M -8.92M -7.42M -6.4M -4.89M -2.89M -831K -554K -518K -348K -248K -190K -216K -54K -79K -111K -209K -562K
Cash Acquisitions
n/a n/a -20.06M -10.78M -10.78M -10.78M 9.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-197.13M -186.56M -186.56M -151.62M -151.62M -38.93M -38.93M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
190M 130M 115M 30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-10.86M 22.49M 13.72M 13.97M 18.34M -15.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-25.23M -42.74M -85.06M -124.82M -148.96M -67.61M -30.48M -554K -518K -348K -248K -190K -216K -54K -79K -111K -209K -562K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -16K -44K -78K -113K -144K -204K 165K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-233.73M -233.43M -243.99M -179.99M 114.75M 114.44M 125M 60.97M -32K -32K n/a -147K 241K 27.58M 27.66M 67.01M 66.32M 38.96M
Financial Cash Flow
182.56M 183.31M 240.53M 275.94M 336.51M 335.82M 116.41M 60.94M 66K 66K 64K -163K 422K 27.72M 27.77M 67.09M 66.11M 49.17M
Net Cash Flow
-21.35M -12.11M 44.67M 64.93M 126.92M 225.3M 78.36M 63.56M 3.77M 1.54M -28.91M -29.16M -25.18M 6.6M 9.46M 49.5M 50.04M 35.01M
Free Cash Flow
-186.17M -161.6M -118.22M -92.59M -65.53M -45.8M -8.4M 2.65M 3.73M 1.51M -28.94M -29M -25.6M -21.12M -18.3M -17.59M -16.07M -14.17M